Does the Fetus Limit Antibiotic Treatment in Pregnant Patients with COVID-19?

• Main Authors: Tito Ramírez-Lozada (Author), María Concepción Loranca-García (Author), Claudia Erika Fuentes-Venado (Author), Carmen Rodríguez-Cerdeira (Author), Esther Ocharan-Hernández (Author), Marvin A. Soriano-Ursúa (Author), Eunice D. Farfán-García (Author), Edwin Chávez-Gutiérrez (Author), Xóchitl Ramírez-Magaña (Author), Maura Robledo-Cayetano (Author), Marco A. Loza-Mejía (Author), Ivonne Areli Garcia Santa-Olalla (Author), Oscar Uriel Torres-Paez (Author), Rodolfo Pinto-Almazán (Author), Erick Martínez-Herrera (Author)
• Format: Book
• Published: MDPI AG, 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

During pregnancy, there is a state of immune tolerance that predisposes them to viral infection, causing maternal-fetal vulnerability to the adverse effects of COVID-19. Bacterial coinfections significantly increase the mortality rate for COVID-19. However, it is known that all drugs, including anti...